chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client reported dizziness, nausea 10 minutes after vaccination.  Visibly pale..  Monitored by onsite EMS.  After 15 minutes, patient exited car and vomited.  Returned to car complaining of dizziness.  Remained seated.  Sips of water taken.  Client reported, "I don't like vaccines or anything to do with doctors."  Emotional support provided.  Client monitored for 1 hour.  Reported , "I feel better, not dizzy a little nauseous."  Declined further monitoring.  Driven off site by family member.
Fever, Diarrhea,  chills Narrative:   Other Relevant History:
Site of injection was itchy; Site of injection was red; Site of injection was swollen; This spontaneous case was reported by a consumer and describes the occurrence of   in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included Cortisone cream. On 18-Jan-2021, the redness and itchiness at the site of injection returned.   Reporter did not allow further contact
This case is a part of cluster of 3 cases and is linked to 2012-10349 and 2012-10348 (reported by same reporter, after FLUZONE ID batch number UT4472AA). Initial report received from a healthcare professional on 01 November 2012. A female patient whose age, medical history and concomitant medications were not reported, had received an intradermal dose of FLUZONE ID (batch number UT4472AA, site of administration was not reported) on an unspecified date. On an unspecified date, after vaccination, the patient developed redness down upper arm with extreme tenderness and the patient could not touch the arm. The patient had 6 to 8 inches redness. Corrective treatment and laboratory details were not reported. At the time of this report, the outcome was not reported. List of documents held by sender was none. Follow-up information received from healthcare professional on 25 March 2013. The patient was 43-year-old. The patient has a history of immunocompromise due to unspecified medication for Rheumatoid arthritis. The patient had no illness at the time of vaccination with no adverse event following prior vaccination. The patient received Intradermal FLUZONE on 23 October 2012 in right arm and experienced adverse event on 24 October 2012. The patient applied warm compresses. At the time of this report, the patient's outcome was recovered on unspecified date (approx. 1 week).
autoimmune issues have been escalating; arthritis; This is a spontaneous report from a non-contactable consumer (patient). A 52 years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 52-year, on 26Apr2021 at single dose for COVID-19 immunisation. Medical history included Behcet's, arthritis. Concomitant medication was not reported. The patient previously received first dose of BNT162B2 on 05Apr2021. On 27Apr2021, the patient experienced arthritis and autoimmune issues had been escalating since her second vaccination. She had told her doctor. Both events resulted in Doctor or other healthcare professional office/clinic visit. The outcome of both events was unknown.  Information on the lot/batch number has been requested.
MMRV was given at this appt instead of varicella alone.  Also MMR was given as well.  Therefore the child received two doses of mmr today at the appointment which was a mistake.  the MA reported the error, and the mother was made aware.
erythema multiform 18MAR93 & 22MAR93 reddened throat; t102.5R; all sx resolved by 22MAR93;
About 2 hours after receiving my Moderna Booster shot I was severely hit with Diarrhea for 28 hours. I took Imodium to help slow it down. It?s been about 40 hours now and my stomach is still upset. Also I still have pain at the injection site with a golf ball size lump that seems to be getting smaller now. During the second day my pain in the arm was really bad. It was a whole lot worse then when I received my second dose of Moderna. In fact it was almost triple the pain. I also experienced being a little  dizzy and loopy the first day. These two symptoms were mild.  I also have  a faint headache that started about 20 hours after the Injection
Shoulder and neck pain on the right.  Ulcerative colitis started to flare.  The second shot was not as bad.  The arm was not as bad.  He thinks the first shot was in the joint.
Started as rashes(small red spots here and there). Went to physician, prescribed steroids. Rashes got worse, referred to dermatologist. Then diagnosed as lichen planus.
Received influenza vaccine 1230 10/22/01. at 1500 headache, tightness in throat, wheezing & effort to breathe. continued throughout evening & nigh. still "lump in throat" 10-23-01 am & wheezing 1300 10/23 "wheezy"
Febrile seizure lasting approximately one minute involving all four extremities, followed by about two hours of lethargy and low muscle tone.
Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date on 22-Jul-2022; No adverse event; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date on 22-Jul-2022).    No concomitant product use was reported. Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022. The vial did not undergo any temperature excursions. The patient received half dose. No treatment information was provided.
Redness and swelling at injection site which measured 2 1/2 inches by 1 3/4 inches on 4/3/21 at 11:30 am. Degree of redness had decreased significantly to light pink by 9:30 pm on 4/3/21. No increase or decrease in size was noted.
burning skin rash on feet and legs for the last 3 days; A spontaneous report was received from a Consumer concerning a 77-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events skin burning sensation.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 6 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 032H20A) in left arm for prophylaxis of COVID-19 infection.  On an unknown date the patient experienced skin burning sensation.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, skin burning sensation was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
pt recv vax MAY96 & 15NOV96 pt devel 3 isolated lesions on forehead & 3 isolated lesions on back;18NOV96 pt lesions were vesicular-like papules that same day devel lesions on wrists, hands,legs & feet;reporter felt pt devel chicken pox;cold
Developed a sore throat on 6/16/22 but tested negative.  I tested positive for COVID-19 on 6/17/22 with a fever, cough, sore throat and sore feet.  Lost my sense of taste and smell on 6/20/22 as well as shortness of breath.  I saw my doctor on 6/24/22 and received anti-virals and cough medicine.
Patient came to pharmacy to show us her bruised arm, 5 days after her first Moderna dose.  I assured her that it was a common side effect and she acknowledged that she had also been told beforehand.
Been dizzy; heart issues; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Been dizzy) and CARDIAC DISORDER (heart issues) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Been dizzy) and CARDIAC DISORDER (heart issues). At the time of the report, DIZZINESS (Been dizzy) and CARDIAC DISORDER (heart issues) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 200 bpm (abnormal) Go under 200 Beats per minute.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No Treatments were reported.
Mid-lower LBP radiating down both legs. Numbness and paresthesias lower legs. Gait imbalance and weakness. Neurologist diagnosed Guillain Barre. On 10/31/14, patient presented to this primary care office with complaints that are listed on the VAERS form. She consulted her neurosurgeon and was referred to a neurologist/pain specialist. Dr. evaluated patient and diagnosed Guillain Barre likely related to the influenza vaccine received in this office on 10/7/14. It was our understanding that he had completed the VAERS form along with his diagnosis. Patient subsequently transferred to a primary care physician who practices within the same network as did the neurologist and neurosurgeon. Neurologist has since relocated, but patient's current records should be available through her current primary care physician, or through the former office of the neurologist listed on the VAERS form. Prior to her transfer to her current primary care physician, this office sent her entire record accumulated during the six months she was a patient here from 8/12/14 - 1/23/15. We have not heard  from her until her recent request for completion of the VAERS form which we were happy to do.
shingles; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), intramuscular, administered in the left arm on 19Apr2021 13:30 (batch/lot number ER8729 and expiry date unknown) at 63 years of age as dose 2, single for covid-19 immunization administered in a clinic ( health clinic/ facility). The patient medical history and concomitant medications were none. The patient previously received dose 1 of BNT162B2, intramuscular, administered in the left arm on 29Mar2021 13:00 (batch/lot number ER8732) at 63 years of age for covid-19 immunization. On 16May2021, the patient experienced shingles. The patient informed that he didn't know if the company has any history of this, but he got his second COVID-19 shot and he got shingles after that. The event required visit to emergency room. The event was reported serious as an important medical event. The patient received treatment of acyclovir, gabapentin due to the event. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
First shot left arm at injection site hurt. ~3days. Second shot left arm at injection site hurt.~2 ? Days . Day 2 all joints were painful felt like cracking . Crps in right arm. Intense sharp pain radiating from surgical scar. Burning.  Today is day 6 . By day 4 all other symptoms gone but I have a flare from crps that is getting worse. Treatment same crps protocol addition vitamins  to see if it helps.
pt recv vax; persistent inconsolable crying lasting 3 hr w/in 1st 10 hr;
She began to have a headache the day after the vaccine was given.  The headache is on the top of her head.  She reports that the area feels heavy.   Doesn't normally have headaches like this.
Fever, muscle and body aches, chills, headache. No treatment except sleep. Effects lasted about 24 hours.
She got the vaccine, could feel where they gave her the vaccine, but nothing.  The next morning she woke up with fever of 100.5, cough starting and a runny nose that was clear to begin with.  Then it started to turn yellow/green and she continued with a very bad cough that got worse.  She took Tylenol for the aches and fever.  She had loss of appetite and continued to drink a lot of water and fluids.  By Friday she no longer had the fever, but still had the intense mucus production.  She saw her doctor on 5/22/23 and mentioned that she had symptoms from the vaccine, but he said OK.  She finally started feeling better and completely back to normal just a few days ago.  The symptoms lasted for about 3 1/2 weeks.    When she went to the doctor and mentioned it and asked if it was the rain or maybe mold that could have caused the symptoms.  He asked if it was gone already and asked if she had reported it, she had lost the paper and he told her that it could be the mold as they are allergic to it.  There was no mold at that time, and she never went outside during the rain.
Developed fever and rash affecting both arms and both legs approximately 1 week after vaccine administration.  Was initially treated as cellulitis with bactrim started 1/14/21. also started OTC benadryl. Seen in ER 1/16/21, determined to be vaccine reaction, given oral prednisone, followed by improvement in symptoms.
Information has been received from a nurse concerning a female who on 06-JUN-2008 was vaccinated with her first dose of GARDASIL (lot# not reported). Concomitant therapy included VARIVAX, for the treatment of prophylaxis (duration and dose not reported) (lot# not reported). Other concomitant therapy included MENACTRA (lot# not reported). On 06-JUN-2008, after receiving the 3 different vaccines, the patient experienced a metallic in her mouth. She brushed her tongue 20 times, but she could still taste it. The patient's metallic taste in her mouth persisted. The patient sought unspecified medical attention on an unspecified date when her mom called the office. Additional information has been requested.
Hard to function after 2nd booster; Extreme fatigue after 2nd booster/still has Extreme fatigue; Low grade fever after 2nd booster; This spontaneous case was reported by a medical assistant and describes the occurrence of LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Hard to function after 2nd booster), FATIGUE (Extreme fatigue after 2nd booster/still has Extreme fatigue) and PYREXIA (Low grade fever after 2nd booster) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049L21A, 013F21A, 026A21A and 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation, GERD and Graves' disease. Concomitant products included METOPROLOL SUCCINATE, THIAMAZOLE (METHIMAZOLE) and FAMOTIDINE for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-May-2022, the patient experienced FATIGUE (Extreme fatigue after 2nd booster/still has Extreme fatigue) and PYREXIA (Low grade fever after 2nd booster). On 21-May-2022, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Hard to function after 2nd booster). In May 2022, PYREXIA (Low grade fever after 2nd booster) had resolved. At the time of the report, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Hard to function after 2nd booster) outcome was unknown and FATIGUE (Extreme fatigue after 2nd booster/still has Extreme fatigue) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported of taking unknown supplements and declined for its name. Patient believed that with 2nd booster shot the side effects progressed more No treatment medications was reported.   This case was linked to MOD-2022-573656, MOD-2022-573658 (Patient Link).
Nodule size of a quarter on the injection site; Injection site warm to touch; Injection site red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (Nodule size of a quarter on the injection site), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE WARMTH (Injection site warm to touch) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011620A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE NODULE (Nodule size of a quarter on the injection site), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE WARMTH (Injection site warm to touch). At the time of the report, VACCINATION SITE NODULE (Nodule size of a quarter on the injection site), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE WARMTH (Injection site warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
Case number PHEH2013US021218 is an initial spontaneous report received from a physician on 08 Oct 2013: This report refers to a 29-year-old female patient. She was vaccinated with a seasonal Influenza vaccine (manufacturer and batch number: unknown) on an undetermined date and experienced aches and pains. The patient recovered on an unknown date. No further information about seriousness and causality was mentioned. The patient was further on vaccinated with seasonal Influenza vaccine for next two subsequent years and experienced aches and pains again (see related cases: PHEH2013US021425 and PHEH2013US021426).
hospital with flu never again no shots for me/ Suepctd VF; hospital with flu never again no shots for me; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   Previously administered products included Flu vaccine with an associated reaction of malaise (received flu vaccine and got sick, refer case US2020AMR180806).   On an unknown date, the patient received Influenza vaccine. On an unknown date, less than a year after receiving Influenza vaccine, the patient experienced vaccination failure (serious criteria hospitalization and GSK medically significant) and influenza (serious criteria hospitalization). On an unknown date, the outcome of the vaccination failure and influenza were unknown.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received flu shot in 2016 and patient was hospitalized 2 days in hospital with flu. The patient stated that the patient never had shot again. The case was considered as suspected vaccination failure since the details regarding time to onset and laboratoty confirmation was not known.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR180806:same reporter
Information has been received from a health professional concerning her 15 month old grandson who on 05Jun04 was vaccinated SC with a 0.5ml dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot not available). Secondary suspect therapy included vaccination on 05Jun04 with a dose of varicella virus vaccine live (lot not available). Subsequently, he has been sick on and off for three weeks. He first broke out with a faint rash. On 08Jun04, he had a fever of 102.5, was fussy and had no appetite. He went to the doctor and they sent him home, thinking it was viral or vaccine related. On 11Jun04, he broke out in a pronounced rash all over his face and torso. The spots were very distinct. He developed a deep cough, but his chest was clear. The rash eventually faded. On 13Jun04, he developed erythema and bumps around the injection site about the size of a quarter. The bumps looked like chicken pox lesions. The pt went to the doctor again. The doctor thought it was vaccine related. The only treatment the pt received was acetaminophen (Tylenol) for fever). No further information is available.
Pt recvd 2 doses of Engerix-B & 6 hrs following 1st dose devel nausea & vomiting which resolved; a few hrs p/recveiving 2nd dose devel coughing, nausea, insomnia, restlessness & heart palpitation which partially resolved;
Pt with Celiac disease and Addison's disease came to the ED for nausea, vomiting, and fever. Pt was found to be COVID positive. Pt admitted for undifferentiated shock.